These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 12018775)

  • 21. Delayed myelination in a mouse model of fragile X syndrome.
    Pacey LK; Xuan IC; Guan S; Sussman D; Henkelman RM; Chen Y; Thomsen C; Hampson DR
    Hum Mol Genet; 2013 Oct; 22(19):3920-30. PubMed ID: 23740941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
    el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
    Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development.
    Slegtenhorst-Eegdeman KE; de Rooij DG; Verhoef-Post M; van de Kant HJ; Bakker CE; Oostra BA; Grootegoed JA; Themmen AP
    Endocrinology; 1998 Jan; 139(1):156-62. PubMed ID: 9421410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
    Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
    Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal proteome comparison of infant and adult Fmr1 deficiency mice reveals adult-related changes associated with postsynaptic density.
    Yang C; Huang YT; Yao YF; Fu JY; Long YS
    J Proteomics; 2024 Jul; 303():105202. PubMed ID: 38797434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
    Koekkoek SK; Yamaguchi K; Milojkovic BA; Dortland BR; Ruigrok TJ; Maex R; De Graaf W; Smit AE; VanderWerf F; Bakker CE; Willemsen R; Ikeda T; Kakizawa S; Onodera K; Nelson DL; Mientjes E; Joosten M; De Schutter E; Oostra BA; Ito M; De Zeeuw CI
    Neuron; 2005 Aug; 47(3):339-52. PubMed ID: 16055059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of Fmrp in zebrafish: evolutionary dynamics of the fmr1 gene.
    van 't Padje S; Engels B; Blonden L; Severijnen LA; Verheijen F; Oostra BA; Willemsen R
    Dev Genes Evol; 2005 Apr; 215(4):198-206. PubMed ID: 15818485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
    Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
    Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.
    Tang B; Wang T; Wan H; Han L; Qin X; Zhang Y; Wang J; Yu C; Berton F; Francesconi W; Yates JR; Vanderklish PW; Liao L
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):E4697-706. PubMed ID: 26307763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A decade of molecular studies of fragile X syndrome.
    O'Donnell WT; Warren ST
    Annu Rev Neurosci; 2002; 25():315-38. PubMed ID: 12052912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features.
    Peier AM; McIlwain KL; Kenneson A; Warren ST; Paylor R; Nelson DL
    Hum Mol Genet; 2000 May; 9(8):1145-59. PubMed ID: 10767339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice.
    Sabanov V; Braat S; D'Andrea L; Willemsen R; Zeidler S; Rooms L; Bagni C; Kooy RF; Balschun D
    Neuropharmacology; 2017 Apr; 116():71-81. PubMed ID: 28012946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.
    Louhivuori V; Vicario A; Uutela M; Rantamäki T; Louhivuori LM; Castrén E; Tongiorgi E; Akerman KE; Castrén ML
    Neurobiol Dis; 2011 Feb; 41(2):469-80. PubMed ID: 21047554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.
    Nielsen DM; Derber WJ; McClellan DA; Crnic LS
    Brain Res; 2002 Feb; 927(1):8-17. PubMed ID: 11814427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome.
    Wahlstrom-Helgren S; Klyachko VA
    J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transport kinetics of FMRP containing the I304N mutation of severe fragile X syndrome in neurites of living rat PC12 cells.
    Schrier M; Severijnen LA; Reis S; Rife M; van't Padje S; van Cappellen G; Oostra BA; Willemsen R
    Exp Neurol; 2004 Oct; 189(2):343-53. PubMed ID: 15380484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    Ruby K; Falvey K; Kulesza RJ
    Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology of the fragile X mental retardation protein, an RNA-binding protein.
    Khandjian EW
    Biochem Cell Biol; 1999; 77(4):331-42. PubMed ID: 10546896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
    Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U
    Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.